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The mechanisms of the systemic response associated with talc-induced pleurodesis are poorly
understood. The aim of this study was to assess the acute inflammatory response and migration
of talc of small size particles injected in the pleural space.
Rabbits were injected intrapleurally with talc solution containing small or mixed particles
and blood and pleural fluid samples were collected after 6, 24 or 48 h and assayed for leuko-
cytes, neutrophils, lactate dehydrogenase, IL-8, VEGF, and TGF-beta. The lungs, spleen, liver
and kidneys were assessed to study deposit of talc particles.
Both types of talc produced an acute serum inflammatory response, more pronounced in the
small particles group. Pleural fluid IL-8 and VEGF levels were higher in the small particle talc
group. Correlation between pleural VEFG and TGF-beta levels was observed for both groups.
Although talc particles were demonstrated in the organs of both groups, they were more
pronounced in the small talc group.
In conclusion, intrapleural injection of talc of small size particles produced a more
pronounced acute systemic response and a greater deposition in organs than talc of mixed
particles.
ª 2008 Elsevier Ltd. All rights reserved.State of Sa˜o Paulo Research
nal Board of Scientific and
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Talc is the most extensively used agent for pleurodesis
because of its wide availability and high rate of therapeutic
success.1 However, side effects associated with the intra-
pleural instillation of talc have been reported, particularly
dyspnea,2e4 that may be severe and manifest as acute.
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The pathophysiology of the syndrome associated with talc
pleurodesis is poorly understood and mainly involve diffuse
pneumonitis, which is not observed with the use of other
sclerosing agents.5e14 Several mechanisms have been
proposed to explain talc-associated pneumonitis, including
extension of the pleural inflammation to the lung paren-
chyma,15 the possible absorption of talc contaminants and
the instillation of high doses of talc.1,14,16e18
Another potential side effect of talc pleurodesis is the
migration of talc particles from the pleural cavity to the
systemic circulation,1,5,14,18e23 and it has been speculated
that smaller talc particles (less than 10 mm) may more
easily migrate to the bloodstream 22e24 and contribute to
the talc-associated pneumonitis.25 Since the talc used for
pleurodesis in Brazil presents a wide variation in particle
size (6.4e50.5 mm),15,26 with 10% of the particles measuring
less than 10 mm, we calculate that in pleurodesis induced
with 5 g of talc about 500 mg of this agent consists of small
particles, corresponding to a substantial amount instilled
into the pleural cavity.
In the present study, we characterized the systemic and
pleural inflammatory response of two types of talc, one
with particles of variable size used traditionally for pleu-
rodesis and one with particles of small size (less than
10 mm). Our hypothesis is that the smaller talc particles are
responsible for the more intense acute systemic inflam-
matory response associated with talc pleurodesis.
Methods
The study was approved by the Ethics Committees for the
analysis of research projects in humans and animals of
Heart Institute (InCor), Hospital das Clı´nicas da Faculdade
de Medicina da Universidade de Sa˜o Paulo, Sa˜o Paulo,
Brazil.
Talc particles
Asbestos-free talc [Mg6(Si8O20)(OH)4] of ‘‘mixed size’’
(Magnesita, Brumado, BA, Brazil), routinely used for pleu-
rodesis, which contains particles of varied size (mean size:
25.4 mm, range:6.4e50.5 mm e only 10% of particles smaller
than 6.66 mm), and small size talc, calibrated to 10 mm
maximum diameter (Sigma-Aldrich Chemical Company,
Milwaukee, WI, USA; mean size: 4.2 mm, range: 1.6e7.3 mm
e with 50% of particles smaller than 6.41 mm) were used in
this study.
The size of the talc particles was confirmed by granulo-
metric analysis using laser diffraction (Malvern Instruments
e Malvern, UK). The chemical composition of the talc
particles was analyzed by X-Ray fluorescence spectrometry
in the Laboratory of Environmental Pollution of the Medical
College of the University of Sa˜o Paulo. Both analyses showed
no difference between both talc samples.
Intrapleural injections
Two groups of 15 New Zealand rabbits (2e2.5 kg) received
3-mL intrapleural injection of 400 mg/kg of either ‘‘mixed’’
or ‘‘small’’ talc diluted in sterile saline. One group of 10rabbits received intrapleural saline as control. Blood
samples were collected before and 6, 24 or 48 h after the
instillation of the agents studied for the determination of
biochemical, cytological and cytokine measurements.
Blood and pleural fluid samples were collected into
tubes containing EDTA for cytological analysis and into dry
tubes for the measurement of lactate dehydrogenase (LDH)
and cytokines (IL-8, VEGF and TGF-b).
For the surgical procedure, the animals were anes-
thetized by intramuscular injection of 35 mg/kg ketamine
(Crista´lia, Sa˜o Paulo, SP, Brazil) plus 5 mg/kg xylazine
(Bayer, Sa˜o Paulo, SP, Brazil), followed by antisepsis with
iodine solution (Rioquı´mica, Sa˜o Paulo, SP, Brazil). Next,
the different solutions were instilled with a 21-G needle
(BectoneDickinson, Sa˜o Paulo, SP, Brazil) into the right
pleural cavity as described in detail elsewhere.15,27e29
After instillation, the entire injection system was immedi-
ately removed to prevent the inadvertent entry of air into
the pleural space. After the procedure, the animals were
monitored for clinical evidence of pain (vocalization,
dyspnea or agitation), and no analgesics were necessary.
The animals were sacrificed after 6, 24 or 48 h by
a lethal injection of pentobarbital (60 mg/kg) through the
marginal ear vein. To avoid inadvertent contamination of
the materials with talc particles, the experiments were
performed by the same examiner (EHG) who used talc-free
gloves and each group was operated upon on different
days.
Cytological and biochemical analysis
Blood and pleural fluid samples were collected into tubes
containing EDTA for cytological analysis and into dry tubes
for the measurement of lactate dehydrogenase (LDH) and
cytokines. The cytology samples were stained with Leish-
man’s stain for the determination of total leukocyte count
and neutrophil percentage. LDH was measured by a kinetic
UV method (normal serum levels ranging from 120 to
240 IU/L).
For the determination of cytokines, the supernatant of
the samples was separated, aliquoted and stored in
a freezer at 80 C for subsequent analysis. IL-8 (OptEIA,
rabbit IL-8 set; Pharmingen, San Diego, CA, USA), VEGF and
TGF-b (R&D Systems, Minneapolis, MN, USA) were measured
by enzyme-linked immunosorbent assay (ELISA) using the
protocol suggested by the manufacturer and adapted for
this study. Cytokines were quantified by the measurement
of optical density in an ELISA reader (Power Wave, Bio-Tek,
Winooski, VT, USA).
Tissue analysis
The thorax of the animalswas removedenbloc and50 mL10%
formaldehyde was injected into the trachea to prevent lung
collapse and to facilitate histological analysis. The other
organs (liver, spleen and kidneys) were removed and sepa-
rately immersed in formalin for 48 h. For histological analysis
by light microscopy, fragments were removed from the
organs, embedded in paraffin, cut into 3-mm sections, and
stained with hematoxylin-eosin (HE). Collection of the frag-
ments was standardized in order to guarantee homogenous
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obtained from the inferior lobe. The other organs were
sectioned transversely and fragments including the hilum of
the organs were chosen as the most representative.
The presence of talc particles in the organs was analyzed
by polarized light microscopy. The Leica Qwin image anal-
ysis program (Leica Q500IV Image Analysis System e Leica
Imaging Systems Ltd., Heerbrugg, Switzerland), was used
for microscopic analysis of the lungs (40 magnification).
Talc particles were quantified in 10 fields and the results are
reported as the ratio between the areas occupied by the
particles (detected by a colorimetric method) and the total
area of the lung parenchyma, spleen, liver and kidneys.
Statistical analysis
The data were analyzed statistically using the SigmaStat
software (San Raphael, CA, USA). Variables showing a normal
distribution are reported as mean and standard deviation,
and those showing no normal distribution are expressed as
median and confidence interval. Blood and pleural fluid
values were compared by analysis of variance (ANOVA) fol-
lowed by the Tukey or Dunn multiple comparisons test when
the difference was significant. Values obtained for small and
mixed particle talc in pleural fluid were compared by the
Student t-test. Pearson’s (normally distributed data) or
Spearman’s (not normally distributed data) correlation test
was used to determine the correlation between the pleural
and serum parameters studied. The ratio of the area occu-
pied by talc to the total lung or organs area was compared
between groups by the Student t-test. A p value <0.05 was
considered to be significant in all tests.30,31
Results
Blood/serum
Leukocytes
Blood leukocytes were found to be significantly elevated
early at 6 h after instillation of the two types of talc
compared to the control group. After 24 h, leukocyte
counts returned close to control values for the mixed talc,
but remained significantly elevated in the small particle
talc group. After 48 h, leukocyte counts returned to control
values for both types of talc (Fig. 1).
Neutrophil percentage
As observed for leukocytes, the percentage of blood
neutrophils was significantly elevated 6 h after instillation
of the two types of talc compared to the control group. The
neutrophil percentage returned close to control levels after
24 h and again increased after 48 h only in the small
particle talc group (data not shown).
Lactate dehydrogenase
In the small talc group, LDH levels followed a similar
pattern as that observed for neutrophil percentage,
increasing over the first 6 h followed by a decrease after
24 h and then increasing again after 48 h. No difference
compared to the control over time was observed for mixed
particle talc (data not shown).Interleukin-8
Serum IL-8 levels were significantly higher for the two types
of talc when compared to control at all times. In addition,
serum IL-8 tended to increase over time in the small
particle talc group compared to the mixed talc group, with
no statistical difference (Fig. 1).
Vascular endothelial growth factor
As observed for IL-8, serum VEGF levels increased during
the first 6 h and remained elevated over time in the two
groups when compared to the control group. No significant
difference was observed for VEGF in the comparison of the
two types of talc (Fig. 1).
Transforming growth factor-b
Higher serum TGF-b levels were observed for mixed talc at
all time points, and for small particle talc group only after
48 h in comparison to control levels. When the two groups
of talc were compared, the serum TGF-b levels were more
pronounced in the mixed talc group at all time points
(Fig. 1).
Pleural fluid (data not shown)
Leukocytes
Total leukocyte counts in pleural fluid were significantly
higher in the mixed talc group compared to the small
particle talc group at all time points, with these values
tending to decrease over time. Leukocyte counts increased
after 24 h in the small particle talc group and again
decreased after 48 h.
Neutrophil percentage
Pleural fluid neutrophils showed an opposite behavior than
that of leukocytes when comparing the two types of talc.
The neutrophil percentage was significantly higher in the
small particle talc group compared to the mixed talc group
at all time points, showing an initial increase and
a tendency to decrease over time.
Lactate dehydrogenase
LDH levels followed a trend similar to that observed for
total leukocyte count in pleural fluid. Significantly higher
levels were observed in the mixed talc group compared to
the small particle talc group after 6 and 24 h, whereas after
48 h LDH levels were higher in the small particle talc group.
Interleukin-8
IL-8 levels in pleural fluid were significantly higher in the
small particle talc group compared to the mixed talc group
at all times.
Vascular endothelial growth factor
As observed for IL-8, VEGF levels in pleural fluid were
higher in the small particle talc group than in the mixed talc
group at all times.
Transforming growth factor-b
As previously stated for the serum levels, pleural TGF-
b levels were higher in the mixed talc group than in the
small particle talc group at all times.
Figure 1 Serum inflammatory markers after intrapleural injection of talc. White blood cell count (WBC) and serum cytokines
after intrapleural injection of small (ST- white bars) or mixed (MT- gray bars) particle talc. (1) WBC rise early at 6 h for both
particles and remain elevated in the ST group until 24 h. After 48 h, WBC returns to normal for both groups. (2) IL-8 levels are higher
than control at all times for both types of talc. (3) VEGF increases early at 6 h in both groups. (4) Higher TGF-b levels are seen in MT
at all time points in comparison to ST (yp< 0.001 and )p< 0.05 vs. control; zp< 0.05 MT vs. ST).
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Correlation between the pleural fluid and blood/serum
parameters revealed a strong correlation only for TGF-
b (RZ 0.80; p< 0.001) in the small particle talc group,
whereas in the mixed talc group a correlation was observed
only for VEGF (RZ 0.74; p< 0.001).
Comparison between the different parameters in each
compartment (pleural fluid or blood) showed positive
correlations only between VEGF and TGF-b in pleural fluid
for both types of talc (small particle talc: RZ 0.94;
p< 0.001; mixed talc: RZ 0.72; p< 0.05) (data not shown).
Tissue analysis
Lungs
In the small particle talc group, talc particles were observed
adhered to the pleural surface and also in the lung paren-
chyma (alveolar spaces and septa) in the right lung (intra-
pleural injection side) (Fig. 2). In the left lung (contralateral
to the injection side), talc particleswere also detected in the
alveolar septa but not in the lung parenchyma (Fig. 2).
In the mixed talc group, talc particles showed a hetero-
geneous distribution on the right pleural surface (side of
injection), with particles rarely being observed in the lung
parenchyma or alveolar septa (Fig. 2). In the left lung, talc
particles were only visible in the alveolar septa (Fig. 2).
Quantification of talc particles in the parenchyma (ratio
of the area occupied by talc to the total tissue area 105)
revealed a significantly larger number of particles in both
lungs in the small particle talc group compared to the
mixed talc group (right lung: 71.1 28.9 vs. 1.18 0.69,p< 0.001; left lung: 68.7 42.4 vs. 1.13 1.14, p< 0.001).
Of note, for both types of talc the particles deposition was
similar in both lungs parenchyma (Fig. 3).
Spleen, liver and kidneys
Analysis of histological sections of the spleen parenchyma
showed the presence of talc particles in the spleen pulp for
both agents. Characteristically, the talc particles were
found aggregated only in the red pulp, whereas the white
pulp was preserved (Fig. 2).
A diffuse distribution of talc particles was also observed
in sections of the liver parenchyma. As a particularity, the
particles were characteristically located in perivascular
regions and therefore more demonstrated close to the hila,
centrolobular vessels and sinusoids (Fig. 2).
In the kidney, talc particles were predominantly detec-
ted in the medullary layer in both groups. Similar to the
findings of other organs, talc particles were also detected
in animals submitted to the intrapleural injection of mixed
talc (Fig. 2).
Quantification of talc particles in the liver and kidneys
showed a significantly larger number of particles in animals
injected with small particle talc (p< 0.05). No significant
difference was observed for the spleen (Fig. 3).
Correlation of the area ratio of talc
in different organs
Analysis of the area ratio of talc in different organs
revealed no positive correlations. In addition, no correla-
tion between cytokine levels and the area ratio of talc was
observed in any of the organs.
Figure 2 Photomicrographs of the lungs and organs emigration of talc particles. Photomicrographs of the lungs and organs. Right
lung: talc particles are noted in the alveolar spaces and septa in both groups, with more particles in the ST (small talc) group than
in the MT (mixed talc) group. Left lung: particles are seen only in alveolar septa with a greater number in the ST group. Liver:
particles are characteristically located in the perivascular regions close to the hila, centrolobular vessels and sinusoids. Kidneys:
particles are noted predominantly in the medullar layer (HE and polarized light, 200).
Figure 3 Particles deposition in the lungs and other organs.
Ratio of talc area vs. total area (105) in lungs, spleen, liver
and kidney. Small talc (ST) has a higher ratio of deposition in
the lungs, liver and kidney ()p< 0.05). No difference was
observed in the spleen.
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Talc, the agent most used for pleurodesis, is known to
produce systemic effects that can culminate in respiratory
insufficiency and even death. The mechanisms underlying
these systemic effects are not completely understood.
Experimental and clinical reports comparing the systemic
effects of talc containing mixed and large particles (larger
than 12 mm23 and 25 mm25) are available in the literature,
but this is the first study that compares the systemic effects
of talc containing mixed particles and talc containing
particles smaller than 5 mm.
Our findings indicate that both small and mixed talc
injected intrapleurally in rabbits produce an acute systemic
inflammatory response. However, small particle talc
produced a more pronounced pleural and systemic response
and resulted in greater particle deposition in the organs
than mixed talc. Both types of talc caused an early increase
in serum leukocyte, IL-8 and VEGF levels compared to
control, but this increase was more marked in the small talc
group. On the other hand, serum and pleural fluid TGF-
b levels showed a more marked increase in the mixed talc
group. Similar to the serum findings, IL-8 and VEGF levels in
pleural fluid were also higher in the small particle talc
96 E.H. Genofre et al.group. Notably, IL-8 levels increased early and decreased
over time, and a correlation between pleural VEGF and
TGF-b levels was observed for both types of particles.
Histological analysis of tissues showed dispersion of both
types of talc particles to all organs studied. However,
analysis of the size of the particles in the organs demon-
strated a greater tissue deposition in animals receiving
small particle talc. Curiously, large amounts of talc parti-
cles were observed in both lungs, with a more pronounced
deposition in the small talc group.
Literature evidence points to a possible migration of talc
particles from the pleural cavity to the systemic circu-
lation.1,5,14,18e23 In an experimental study, Ferrer et al.23
demonstrated the presence of talc particles in different
organs and suggested that small particles might be more
easily absorbed by lymphatic stomata than larger particles.
On the basis of the present observations, the question
remains as to which mechanisms are involved in the
systemic response to intrapleural talc instillation. One
explanation for the systemic inflammatory response would
be the direct passage of particles from the pleural space to
the bloodstream, in agreement with the findings of previous
studies.14,23 In this respect, the same mechanism might
explain the systemic effects observed for mixed talc, since
about 10% of the particles of this type of talc were smaller
than 10 mm.
Talc particles migration mechanisms are still unknown.
One possible mechanism is the lymphatic absorption of talc
particles fromthepleural cavity.However, by thismechanism
itwouldbedifficult toexplain thepresenceof talc particles in
the liver, spleen and kidneys, since these particles migrate
from the pleural cavity to the systemic venous circulation
through the lymphatic routeand return to the lungwhere they
probably are being removed. In this respect, it is also possible
that thepresenceof talc in thealveolimayproducean intense
local inflammation and changes in the alveolar-capillary
barrier, causing reflow of particles to the systemic circula-
tion. In this situation, we would expect diffuse lung injury
whichmight evenbe thecauseof the respiratory insufficiency
observed in talcpleurodesis.However, histological analysis of
the lungs of the animals submitted to intrapleural talc
injection showed no intense acute pulmonary lesions that
would support this mechanism.
A second mechanism would be that of an intense pleural
inflammatory process leading to rupture of the pleural
barrier caused by diffuse mesothelial injury. An important
observation of the present study was that the particles
found in the organs studied were smaller than 5 mm,
a finding strongly suggesting that the systemic effects can
be explained by the presence of small particles.
The leakage of inflammatory mediators from the pleural
space to the bloodstream is suggested by our findings, as
showed that in the pleural cavity IL-8 levels increased early
and decreased over time, whereas the opposite was
observed in blood. In contrast, VEGF levels tended to
increase progressively over time in both pleural fluid and
blood, a finding reflecting an increase in capillary perme-
ability that contributes to both the formation of pleural
fluid and the passage of smaller molecules from the pleural
cavity to the blood circulation.
Comparison of the levels of inflammatory mediators in
pleural fluid and blood showed a strong pleural-serumcorrelation only for TGF-b levels in the small particle talc
group and for VEGF in the mixed talc group, a finding sug-
gesting a possible flow mechanism between the two
compartments. However, these data alone do not allow us
to infer that this is the only mechanism involved in the
systemic response observed in talc pleurodesis. In addition
to the increase in inflammatory mediators, we observed an
acute increase in serum leukocytes and neutrophils in both
talc groups coinciding with the acute pleural-serum
inflammatory response, although no correlation was
observed for these parameters.
A possible pro-inflammatory effect of TGF-b was
demonstrated by the correlation that was observed
between VEGF and TGF-b in pleural fluid. This fact was
suggested in a previous study showing that TGF-b stimulates
the production of VEGF by mesothelial cells and thus
explains the increase in vascular permeability observed in
pleurodesis inflammation.32 However, our findings showed
that pleural VEGF levels were higher in the small particle
talc group than in the mixed talc group, whereas pleural
TGF-b levels were higher in animals injected with mixed
talc, suggesting a possible overlap of both distinct inflam-
matory mechanisms, the leakage of inflammatory media-
tors from the pleural space and the systemic effects of talc
particles deposition in organs. In agreement with these
findings, previous experimental study from our group
showed an increase of serum IL-8 and VEGF levels in rabbits
after intrapleural instillation of mixed talc,28 suggesting
that these mediators may reflow from the pleural cavity to
the systemic circulation and are involved in the genesis of
the systemic effects observed in pleurodesis. In addition,
Maskell et al. showed in a clinical trial that talc containing
particles standardized at 15 mm produced a local and
systemic inflammation when compared to tetracycline and
and talc particles larger than 25 mm.25
Our data do not permit any conclusion as to whether the
systemic cellular response is due to the flow of cells from
the pleural cavity to the bloodstream or to a direct
systemic cellular response to the presence of talc particles
in the organs. However, we may speculate that the intense
pleural inflammation caused by talc promotes the loss of
integrity of the pleural barrier, permitting the free flow of
cytokines and talc particles between the two compart-
ments. In a second step, the presence of talc particles in
tissues would trigger a local cellular response that
contributes to the maintenance and amplification of the
systemic inflammatory response. These considerations
indicate that the mechanism underlying the systemic
inflammatory response observed in talc pleurodesis still
needs further investigation. However, it seems reasonable
to assume that the size of the talc particles influences the
inflammatory response and, possibly, the side effects
observed in clinical practice. In this respect, future studies
correlating the cellular response with the number of
particles deposited in tissues may contribute to clarify this
question.Conclusions
In conclusion, talc containing particles of small size injec-
ted into the pleural space of rabbits produced a more
Acute systemic response to talc pleurodesis 97intense systemic and pleural inflammatory response than
mixed particle talc. Particles of both types of talc were
detected in the lungs, spleen, liver and kidneys of the
animals studied. These data, together with those obtained
in previous studies, suggests the need for the commercial
development of a type of talc for universal use in pleu-
rodesis that preferentially contains particles larger than
20 mm to permit the clinical use with greater safety and
a lower risk of adverse systemic effects.
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